Description

DILTANOL 30 MG

Indications

DILTANOL 30 MG, which contains the active ingredient Diltiazem, is primarily indicated for the management of hypertension (high blood pressure) and angina pectoris (chest pain). It is also used in the treatment of certain types of arrhythmias, particularly atrial fibrillation and atrial flutter. By effectively lowering blood pressure and reducing the heart’s workload, Diltiazem helps improve overall cardiovascular health and reduces the risk of complications associated with these conditions.

Mechanism of Action

Diltiazem is classified as a calcium channel blocker. It works by inhibiting the influx of calcium ions into cardiac and smooth muscle cells through voltage-gated calcium channels. This action leads to relaxation of vascular smooth muscle, resulting in vasodilation and decreased peripheral vascular resistance. Additionally, Diltiazem decreases myocardial contractility and heart rate, which contributes to its effectiveness in treating angina and arrhythmias. The overall effect is a reduction in myocardial oxygen demand, alleviating symptoms associated with ischemic heart disease.

Pharmacological Properties

Diltiazem exhibits several pharmacological properties that make it effective in treating cardiovascular conditions. It has a rapid onset of action, typically within 30 to 60 minutes after oral administration, with a peak effect occurring within 2 to 3 hours. The drug has a half-life of approximately 3 to 4.5 hours, necessitating multiple daily doses for sustained therapeutic effect. Diltiazem is extensively metabolized in the liver, primarily through cytochrome P450 enzymes, and its metabolites are excreted through the urine. The drug’s bioavailability is variable, ranging from 30% to 70%, depending on the formulation and individual patient factors.

Contraindications

DILTANOL 30 MG is contraindicated in patients with known hypersensitivity to Diltiazem or any of its components. It should not be used in individuals with severe hypotension (blood pressure less than 90 mmHg), advanced atrioventricular block (unless a pacemaker is present), sick sinus syndrome, or acute myocardial infarction with pulmonary congestion. Caution is advised in patients with heart failure, hepatic impairment, or renal dysfunction, as these conditions may alter the drug’s pharmacokinetics and increase the risk of adverse effects.

Side Effects

Common side effects associated with DILTANOL 30 MG include dizziness, headache, flushing, and peripheral edema. Gastrointestinal disturbances such as nausea, vomiting, and constipation may also occur. More serious side effects, although less common, include bradycardia, hypotension, and exacerbation of heart failure. Patients should be monitored for signs of liver dysfunction, as elevated liver enzymes have been reported in some cases. If any severe or unusual symptoms occur, patients should seek medical attention promptly.

Dosage and Administration

The recommended starting dose of DILTANOL 30 MG for adults is typically 30 mg taken orally three times a day. Depending on the clinical response and tolerability, the dosage may be adjusted, with a maximum daily dose not exceeding 360 mg. It is advisable to take the medication at the same times each day to maintain consistent blood levels. Diltiazem can be taken with or without food, but patients should be encouraged to follow their healthcare provider’s instructions regarding specific dosing and administration guidelines.

Interactions

Diltiazem has the potential to interact with various medications, which may alter its effectiveness or increase the risk of adverse effects. Notable interactions include other antihypertensive agents, which may lead to additive hypotensive effects. Caution should also be exercised when Diltiazem is used in conjunction with beta-blockers, as this combination may result in bradycardia or heart block. Additionally, Diltiazem may inhibit the metabolism of drugs that are substrates of cytochrome P450 3A4, such as certain statins and benzodiazepines, necessitating dose adjustments for these medications. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.

Precautions

Before initiating treatment with DILTANOL 30 MG, a thorough medical history should be obtained, and a physical examination should be conducted. Patients with pre-existing heart conditions, liver or kidney impairment, or those who are pregnant or breastfeeding should use Diltiazem with caution. Regular monitoring of blood pressure and heart rate is essential, particularly during the initial stages of therapy. Patients should be advised to avoid abrupt discontinuation of the medication, as this may lead to rebound hypertension or exacerbation of angina symptoms.

Clinical Studies

Clinical studies have demonstrated the efficacy of Diltiazem in managing hypertension and angina. A randomized controlled trial published in the Journal of Hypertension showed that Diltiazem significantly reduced systolic and diastolic blood pressure compared to placebo, with a favorable safety profile. Another study in the American Journal of Cardiology indicated that Diltiazem effectively improved exercise tolerance and reduced angina episodes in patients with stable angina. These findings support the use of Diltiazem as a first-line treatment option for patients with cardiovascular conditions requiring management of blood pressure and angina.

Conclusion

DILTANOL 30 MG is a well-established medication for the treatment of hypertension and angina pectoris. Its mechanism of action as a calcium channel blocker allows for effective management of cardiovascular conditions by reducing blood pressure and alleviating angina symptoms. While generally well-tolerated, it is essential for patients to be aware of potential side effects, drug interactions, and contraindications. Regular follow-up with healthcare providers is crucial to ensure optimal therapeutic outcomes and to monitor for any adverse effects. With appropriate use, Diltiazem can significantly improve the quality of life for patients with cardiovascular diseases.